Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSamsung Medical Center

About this trial

The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of acute myocardial infarction

Undergoing percutaneous coronary intervention or coronary artery bypass surgery

Disqualifiers

Pre-existing phychiatric disorders

Trial population

dults aged ≥18 years who were hospitalized between January 1, 2009, and December 31, 2023, with a primary diagnosis of AMI, defined using ICD-10 codes I21-I23 along with procedure codes for revascularization (either PCI or CABG), were included (N = 318,356). Among the participants, we excluded patients with mental disorder prior to incident MI (N =79,133), and patients who die at the diagnosis of AMI (N = 3,881).

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Insomnia medication

    Drug

    Diagnosed as insomnia and use of anti-insomnia medication

  • No insomnia medication

    Other intervention

    Diagnosed as insomnia and did not use of anti-insomnia medication

Treatment groups

235,342 Participants
are divided into 2 treatment groups
Group A: No insomina0 interventions
Group B: Insomnia2 interventions

Trial outcomes

Primary outcomes

1

Rates of MACCE

a composite of death, spontaneous MI, repeat revascularization, and ischemic stroke

Time frame
up to 10 years

Secondary outcomes

1

Rates of Death

All-cause death

Time frame
up to 10 years
2

Rates of Revascularization

repeat revascularization

Time frame
up to 10 years
3

Rates of Spontaneous MI

MI

Time frame
up to 10 years
4

Rates of Ischemic stroke

Stroke

Time frame
up to 10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: